State Of Alaska, Department Of Revenue Biomarin Pharmaceutical Inc Transaction History
State Of Alaska, Department Of Revenue
- $8.95 Billion
- Q4 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 21,730 shares of BMRN stock, worth $1.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,730
Previous 29,225
25.65%
Holding current value
$1.5 Million
Previous $2.05 Million
30.44%
% of portfolio
0.02%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.56 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.33 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.25 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.01 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$894 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...